Beyond AI predictions: Building a continuous learning system for drug discovery
Explore how trusted Lab-in-the-Loop systems connect AI, laboratory experimentation and scientific evidence to improve drug-discovery decisions.
BC Platforms supports national pathway for cancer vaccine trials
A newly published BMJ Open paper sets out the design of the Cancer Vaccine Launch Pad (CVLP), a national initiative developing pathways to help people with cancer access clinical trials for cancer vaccines and other targeted immunotherapies.
Sponsored by NHS England and coordinated by the Cancer Research UK Southampton Clinical Trials Unit at the University of Southampton, the CVLP brings together patient referral, tumor tissue processing and genomic profiling as part of a national approach to identifying and referring patients to relevant clinical trials.
The paper highlights how this coordinated approach could improve access to cancer vaccine and targeted immunotherapy trials, while helping prepare the NHS for broader adoption of these treatments if they become part of routine care.
BC Platforms co-developed and manages the CVLP’s central electronic referral tool with the Southampton Clinical Trials Unit, supporting the coordination of patient referrals across participating NHS locations.
Päivi Tikka-Kleemola, Lead Product Manager at BC Platforms, is a co-author of the newly published protocol.